XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Note 8, Stock Based Compensation | 9 Months Ended
--- | ---
Jun. 30, 2017
Share-based Compensation [Abstract] |
Disclosure of Compensation Related Costs, Share-based Payments [Text Block] |
Note 8. | STOCK-BASED COMPENSATION
Adient provides certain key employees equity awards in the form of performance share units (PSUs) and restricted stock units (RSUs) under the Adient plc 2016 Omnibus Incentive Plan and provides directors with share awards under the Adient plc 2016 Director Share Plan. These plans were adopted in conjunction with the separation. Total cash and non-cash stock-based compensation cost included in the consolidated statements of income was $11 million and $33 million for the three and nine months ended June 30, 2017, respectively, and $14 million and $20 million for the three and nine months ended June 30, 2016, respectively. Stock-based compensation expense prior to the separation was allocated to Adient based on the portion of Adient's equity compensation programs in which Adient employees participated. In conjunction with the separation, previously outstanding stock-based compensation awards granted under JCI's equity compensation programs prior to the separation and held by certain executives and employees of Adient were adjusted and converted into new Adient equity awards using a formula designated to preserve the intrinsic value of the awards. Upon the separation on October 31, 2016, holders of JCI stock, stock options, RSUs, and SARs generally received one ordinary share of Adient for every ten ordinary shares of JCI held at the close of business on October 19, 2016, the record date of the distribution, and cash in lieu of fractional shares (if any) of Adient. Accordingly, certain executives and employees of Adient hold converted awards in both JCI and Adient shares subsequent to the separation. Converted awards retained the vesting schedule and expiration date of the original awards. Outstanding stock awards related to JCI stock are not included in Adient's dilutive share calculation. The following tables present activity related to the conversion and granting of awards during the nine months ended June 30, 2017 along with the composition of outstanding and exercisable awards at June 30, 2017 for remaining JCI and new Adient awards. Stock Options A summary of stock option activity for the nine months ended June 30, 2017:
|  | Weighted Average Option Price |  | Shares Subject to Option |  | Weighted Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value (in millions)
Outstanding, September 30, 2016 |  | $ | 32.42 |  |  | 2,336,028 |  |  |  |  |
Exercised |  | 27.22 |  |  | (6,280 | ) |  |  |  |
Forfeited or expired |  | 31.71 |  |  | (3,330 | ) |  |  |  |
Converted |  | 33.28 |  |  | 169,125 |  |  |  |  |
Converted and outstanding on October 31, 2016 |  | 32.49 |  |  | 2,495,543 |  |  |  |  |
Granted |  | — |  |  | — |  |  |  |  |
Exercised |  | 27.13 |  |  | (922,734 | ) |  |  |  |
Forfeited or expired |  | 26.10 |  |  | (3,083 | ) |  |  |  |
Outstanding, June 30, 2017 |  | $ | 35.65 |  |  | 1,569,726 |  |  | 4.8 |  | $ | 23 |
Exercisable, June 30, 2017 |  | $ | 29.67 |  |  | 1,298,785 |  |  | 4.1 |  | $ | 22 |
JCI outstanding, June 30, 2017 |  | $ | 35.97 |  |  | 1,354,043 |  |  | 4.9 |  | $ | 16 |
Adient outstanding, June 30, 2017 |  | 33.67 |  |  | 215,683 |  |  | 4.1 |  | 7 |
Total outstanding, June 30, 2017 |  | $ | 35.65 |  |  | 1,569,726 |  |  | 4.8 |  | $ | 23 |
JCI exercisable, June 30, 2017 |  | $ | 29.28 |  |  | 1,107,731 |  |  | 4.2 |  | $ | 16 |
Adient exercisable, June 30, 2017 |  | 31.90 |  |  | 191,054 |  |  | 3.6 |  | 6 |
Total exercisable, June 30, 2017 |  | $ | 29.67 |  |  | 1,298,785 |  |  | 4.1 |  | $ | 22 |
At June 30, 2017, Adient had approximately $0.3 million of total unrecognized compensation cost related to nonvested stock options granted. That cost is expected to be recognized over a weighted-average period of 1.1 years. Stock Appreciation Rights A summary of SAR activity for the nine months ended June 30, 2017:
|  | Weighted Average SAR Price |  | Shares Subject to SAR |  | Weighted Average Remaining Contractual Life (years) |  | Aggregate Intrinsic Value (in millions)
Outstanding, September 30, 2016 |  | $ | 31.26 |  |  | 654,694 |  |  |  |  |
Exercised |  | 29.68 |  |  | (9,470 | ) |  |  |  |
Converted |  | 33.16 |  |  | 41,713 |  |  |  |  |
Converted and outstanding on October 31, 2016 |  | 31.40 |  |  | 686,937 |  |  |  |  |
Granted |  | — |  |  | — |  |  |  |  |
Exercised |  | 31.20 |  |  | (50,266 | ) |  |  |  |
Forfeited or expired |  | 48.32 |  |  | (4,757 | ) |  |  |  |
Outstanding, June 30, 2017 |  | $ | 31.29 |  |  | 631,914 |  |  | 3.7 |  | $ | 11 |
Exercisable, June 30, 2017 |  | $ | 27.95 |  |  | 594,610 |  |  | 3.5 |  | $ | 10 |
JCI outstanding, June 30, 2017 |  | $ | 31.22 |  |  | 571,699 |  |  | 3.7 |  | $ | 9 |
Adient outstanding, June 30, 2017 |  | 32.01 |  |  | 60,215 |  |  | 3.8 |  | 2 |
Total outstanding, June 30, 2017 |  | $ | 31.29 |  |  | 631,914 |  |  | 3.7 |  | $ | 11 |
JCI exercisable, June 30, 2017 |  | $ | 27.61 |  |  | 537,786 |  |  | 3.5 |  | $ | 8 |
Adient exercisable, June 30, 2017 |  | 31.11 |  |  | 56,824 |  |  | 3.5 |  | 2 |
Total exercisable, June 30, 2017 |  | $ | 27.95 |  |  | 594,610 |  |  | 3.5 |  | $ | 10 |
Restricted Stock A summary of the activity of nonvested restricted stock awards for the nine months ended June 30, 2017:
|  | Weighted Average Price |  | Shares/Units Subject to Restriction
Nonvested, September 30, 2016 |  | $ | 46.42 |  |  | 1,320,448 |
Converted |  | 48.06 |  |  | 135,026 |
Converted and nonvested on October 31, 2016 |  | 46.57 |  |  | 1,455,474 |
Granted |  | 45.19 |  |  | 1,162,213 |
Vested |  | 50.30 |  |  | (281,084 | )
Forfeited |  | 44.65 |  |  | (47,297 | )
Nonvested, June 30, 2017 |  | $ | 45.46 |  |  | 2,289,306 |
JCI nonvested, June 30, 2017 |  | $ | 45.57 |  |  | 1,031,972 |
Adient nonvested, June 30, 2017 |  | 45.41 |  |  | 1,257,334 |
Total nonvested, June 30, 2017 |  | $ | 45.46 |  |  | 2,289,306 |
At June 30, 2017, Adient had approximately $63 million of total unrecognized compensation cost related to nonvested restricted stock arrangements granted. That cost is expected to be recognized over a weighted-average period of 2.1 years. Performance Share Awards A summary of the activity of nonvested performance-based share unit awards for the nine months ended June 30, 2017:
|  | Weighted Average Price |  | Shares/Units Subject to PSU
Nonvested, September 30, 2016 |  | $ | — |  |  | — |
Converted and nonvested on October 31, 2016 |  | — |  |  | — |
Granted |  | 44.60 |  |  | 236,034 |
Vested |  | — |  |  | — |
Forfeited |  | — |  |  | — |
Nonvested, June 30, 2017 |  | $ | 44.60 |  |  | 236,034 |
At June 30, 2017, Adient had approximately $17 million of total unrecognized compensation cost related to nonvested performance share units granted. That cost is expected to be recognized over a weighted-average period of 2.4 years.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration